SCHEMBL7865396

SCHEMBL7865396

COC(=O)CCC(=O)c1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.58
CTNNB1 P35222 2/20 0.55
WNT3A P56704 2/20 0.55
MAPT P10636 3/20 0.51
POLB P06746 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 4/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
TP53 P04637 1/20 0.48
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 2/20 0.47
FFAR1 O14842 1/20 0.47
CYP1A2 P05177 1/20 0.47
HIF1A Q16665 1/20 0.47
GSK3B P49841 1/20 0.47
ATM Q13315 1/20 0.47
HPGD P15428 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8535748 0.95 KMT2A (0.63) KMT2ACTNNB1WNT3AMAPTPOLB
SCHEMBL6388993 0.90 KMT2A (0.50) KMT2ACTNNB1WNT3AMAPTPOLB
SCHEMBL10001233 0.86 SMN1; SMN2 (0.66) KMT2AMAPTPOLBALDH1A1MEN1
SCHEMBL11824190 0.85 KMT2A (0.56) KMT2ACTNNB1WNT3AMAPTPOLB
SCHEMBL11764964 0.85 LMNA (0.56) KMT2AMAPTPOLBALDH1A1MEN1
SCHEMBL7925389 0.85 KMT2A (0.59) KMT2AMAPTPOLBALDH1A1MEN1
SCHEMBL9077880 0.84 KMT2A (0.55) KMT2ACTNNB1WNT3AMAPTMEN1
SCHEMBL25456558 0.83 KMT2A (0.53) KMT2ACTNNB1WNT3AMAPTMEN1
SCHEMBL7868125 0.82 LMNA (0.56) KMT2AMAPTPOLBALDH1A1MEN1
SCHEMBL16552778 0.81 KMT2A (0.83) KMT2ACTNNB1WNT3AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010000513-A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases WARNER-LAMBERT COMPANY 2001-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010000513-A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases MMP26, MMP1, MMP9 KMT2A 4671/4885CTNNB1 684/4885WNT3A 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.